Oragenics Enters into Licensing Agreement with the National Research Council of Canada, to Pursue the Rapid Development of Next-Generation SARS-CoV-2 Vaccines
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced it has entered into a licensing agreement with the National Research Council of Canada (NRC) that will enable Oragenics to pursue the rapid development of next-generation vaccines against the SARS-CoV-2 virus and its variants.
‘A Year of Change’: UF Reflects on COVID-19 Milestones
The University of Florida is reflecting back on the milestones made in the last year through the COVID-19 pandemic. From the initial lockdown in March 2020 to the rollout of vaccines in December, reflecting back on the year of change helps us see just how far we’ve come.
AxoGen’s Avance Nerve Graft Helps Woman Race Horses Again
Woman returns to horse racing after AxoGen's Avance nerve graft relieved her excruciating foot pain caused by osteoarthritis and surgeries.
UF and Scripps Research Announce Talks To Integrate
In a move designed to marry the clinical and educational expertise of the state’s flagship university with one of the world’s premier biomedical research enterprises, the University of Florida and Scripps Research announced they are in talks to integrate the Florida-based branch of Scripps Research with the research arm of UF’s academic health center.
Fast Nanoparticle Diffusion in Synovial Fluid May Hold Key to Joint Disease Recovery
University of Florida professors Carlos M. Rinaldi-Ramos and Kyle D. Allen, from the Department of Chemical Engineering and the J. Crayton Pruitt Family Department of Biomedical Engineering, are investigating the application of nanoparticles as diagnostic and therapeutic agents for joint diseases, such as osteoarthritis.
Michele Manuel Named 2021 TMS Brimacombe Medalist
Michele Manuel, Ph.D., professor and chair of the UF Department of Materials Science & Engineering, was recently recognized as a Brimacombe Medalist by The Mineral, Metals & Materials Society (TMS).
How a Robot Developed at UF Could Help First Responders See Through Walls During Rescues
A University of Florida research team is working on a robot dog that has the ability to enter an enclosed space, scan it, and provide humans with a visual of what’s inside, an application that could lessen dangerous situations for first responders.
AavantiBio and Aldevron Announce Strategic Partnership To Develop Next-Generation Gene Therapies for Rare Genetic Diseases
UF startup and UF Innovate | The Hub resident AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins and mRNA for the biotech industry, announced a long-term strategic partnership for the supply of plasmid DNA that will enable AavantiBio to advance its platform of innovative gene transfer therapies.
The One Big Threat When It Comes to Cyber-Security Has Nothing To Do With Software
Though malicious software gets most of the attention when it comes to computer security, the biggest cyber-security threat right now is a hardware problem, says Mark Tehranipoor, director of the Florida Institute for Cybersecurity Research (FICS).
UF Neuroscientists Discover Biomarker With Potential To Aid Parkinson’s Diagnosis
University of Florida neuroscientists have developed a new assay, or test, to detect minute amounts of a protein called tyrosine hydroxylase in blood immune cells of Parkinson’s disease patients, a key finding to aid in the development of a blood test to help diagnose and guide treatment for the neurodegenerative disorder.
